Lingqing Xu

625 total citations
30 papers, 481 citations indexed

About

Lingqing Xu is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Lingqing Xu has authored 30 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Lingqing Xu's work include Antibiotic Resistance in Bacteria (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immune Cell Function and Interaction (3 papers). Lingqing Xu is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immune Cell Function and Interaction (3 papers). Lingqing Xu collaborates with scholars based in China, United States and Egypt. Lingqing Xu's co-authors include Qingqin Tan, Guanmin Jiang, Zhaoyan Zhao, Bin Li, Tianchuan Zhu, Haibo Zhou, Xi Huang, Wei Wang, Lantian Tang and Hong Shan and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Lingqing Xu

29 papers receiving 477 citations

Peers

Lingqing Xu
Comparison fields: 5 of 92
  • Infectious Diseases 143
  • Molecular Biology 121
  • Molecular Medicine 87
  • Epidemiology 76
  • Immunology 67
Ehsan Aryan Iran
Krishan Gopal Thakur India
Jafar Salimian Iran
Muhammed A. Bakhrebah Saudi Arabia
Saeid Amel Jamehdar Iran
Cong Cheng China
Adline Princy Solomon India
Kirtimaan Syal India
Qing Mei China
Sarah Schmidt Grant United States
Ehsan Aryan Iran View profile →
Citations per field, relative to Lingqing Xu
Lingqing Xu · 1×
Citations per year, relative to Lingqing Xu
Lingqing Xu · 1×

Countries citing papers authored by Lingqing Xu

Since Specialization
Citations

This map shows the geographic impact of Lingqing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingqing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingqing Xu more than expected).

Fields of papers citing papers by Lingqing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingqing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingqing Xu. The network helps show where Lingqing Xu may publish in the future.

Co-authorship network of co-authors of Lingqing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingqing Xu. A scholar is included among the top collaborators of Lingqing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingqing Xu. Lingqing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 5
3 9
4 3
5 5
6 19
7 1
8 51
9 12
10 3
11 9
12 9
13 1
14 20
15 2
16 10
17 14
18 15
19 14
20 29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026